Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.59% | $163.38M | €456.01B | 69.49% | 76 Outperform | |
| Roche Holding AG | 1.49% | $94.31M | CHF284.70B | 44.00% | 73 Outperform | |
| HSBC Holdings | 1.44% | $90.65M | £224.27B | 52.25% | 80 Outperform | |
| AstraZeneca | 1.40% | $88.34M | $299.27B | 27.68% | 80 Outperform | |
| Novartis AG | 1.35% | $85.52M | CHF228.31B | 23.99% | 80 Outperform | |
| Toyota Motor | 1.32% | $83.48M | ¥49.27T | 31.98% | 80 Outperform | |
| Nestlé SA | 1.23% | $77.40M | CHF199.53B | 21.38% | 71 Outperform | |
| Mitsubishi UFJ Financial Group | 1.03% | $64.97M | ¥33.00T | 55.28% | 76 Outperform | |
| Siemens | 1.02% | $64.65M | €195.46B | 22.39% | 74 Outperform | |
| Shell (UK) | 1.01% | $63.83M | £157.08B | 6.95% | 73 Outperform |